Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
The Virtual Mentor : VM
|
December 25, 2012
Physicians' role in physician-assisted suicide discussions
Wendy S Johnston, Paul Bascom
Neurology
|
February 16, 2011
Amyotrophic lateral sclerosis: ethical challenges
Wendy S Johnston, Katelin Hoskins, Leo McCluskey
Neurology
|
May 24, 2017
Teaching Neuro<i>Images</i>: Intraspinal synovial cyst causing Brown-Séquard syndrome: Uncommon cause of a classic syndrome
Grayson Beecher, Trevor Kotylak, Wendy S Johnston
Neurology
|
August 15, 2002
The final month of life in patients with ALS
Linda Ganzini, Wendy S Johnston, Maria J Silveira
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
September 2, 2025
Asymmetry and alignment: Physician perspective on patient-based evidence for improving health communication
Shelagh K Genuis, Westerly Luth, Wendy S Johnston
Journal of Pain and Symptom Management
|
November 30, 2002
Predictors and correlates of interest in assisted suicide in the final month of life among ALS patients in Oregon and Washington
Linda Ganzini, Maria J Silveira, Wendy S Johnston
BMC Neurology
|
April 13, 2022
Covid-19 threat and coping: application of protection motivation theory to the pandemic experiences of people affected by amyotrophic lateral sclerosis
Shelagh K Genuis, Westerly Luth, Tania Bubela, et al.
Muscle & Nerve
|
July 18, 2023
What do people affected by amyotrophic lateral sclerosis want from health communications? Evidence from the ALS Talk Project
Shelagh K Genuis, Westerly Luth, Tania Bubela, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
November 20, 2025
Patient-based evidence for amyotrophic lateral sclerosis prognostic health communication: "the clock is ticking…how long do I have?"
Shelagh K Genuis, Westerly Luth, Brianna Adams, et al.
Annals of Clinical and Translational Neurology
|
July 8, 2016
Rituximab in refractory myasthenia gravis: a prospective, open-label study with long-term follow-up
Dustin Anderson, Cecile Phan, Wendy S Johnston, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
The Virtual Mentor : VM
|
December 25, 2012
Physicians' role in physician-assisted suicide discussions
Wendy S Johnston, Paul Bascom
Neurology
|
February 16, 2011
Amyotrophic lateral sclerosis: ethical challenges
Wendy S Johnston, Katelin Hoskins, Leo McCluskey
Neurology
|
May 24, 2017
Teaching Neuro<i>Images</i>: Intraspinal synovial cyst causing Brown-Séquard syndrome: Uncommon cause of a classic syndrome
Grayson Beecher, Trevor Kotylak, Wendy S Johnston
Neurology
|
August 15, 2002
The final month of life in patients with ALS
Linda Ganzini, Wendy S Johnston, Maria J Silveira
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
September 2, 2025
Asymmetry and alignment: Physician perspective on patient-based evidence for improving health communication
Shelagh K Genuis, Westerly Luth, Wendy S Johnston
Journal of Pain and Symptom Management
|
November 30, 2002
Predictors and correlates of interest in assisted suicide in the final month of life among ALS patients in Oregon and Washington
Linda Ganzini, Maria J Silveira, Wendy S Johnston
BMC Neurology
|
April 13, 2022
Covid-19 threat and coping: application of protection motivation theory to the pandemic experiences of people affected by amyotrophic lateral sclerosis
Shelagh K Genuis, Westerly Luth, Tania Bubela, et al.
Muscle & Nerve
|
July 18, 2023
What do people affected by amyotrophic lateral sclerosis want from health communications? Evidence from the ALS Talk Project
Shelagh K Genuis, Westerly Luth, Tania Bubela, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
November 20, 2025
Patient-based evidence for amyotrophic lateral sclerosis prognostic health communication: "the clock is ticking…how long do I have?"
Shelagh K Genuis, Westerly Luth, Brianna Adams, et al.
Annals of Clinical and Translational Neurology
|
July 8, 2016
Rituximab in refractory myasthenia gravis: a prospective, open-label study with long-term follow-up
Dustin Anderson, Cecile Phan, Wendy S Johnston, et al.
Page
of 3